Movetis Files RESOLOR(R) With EMEA For The Indication Of Chronic Constipation
Movetis Files RESOLOR(R) With EMEA For The Indication Of Chronic Constipation
|
Movetis announced that the European Medicines Agency (EMeA) has accepted the Marketing Authorization Application (MAA) submission for RESOLOR® (prucalopride) as a treatment for chronic constipation in adults in whom laxatives fail to provide adequate relief. |
read more...
News entry number 4942 added on May 30, 2008 in the Health category.
Comenteaza
Other News in the Health category
Categorie:
Categorie:
Categorie:
Categorie:
Categorie:
Related Links
- Study: Depression More Sickening Than Some Chronic Diseases
- Depression makes chronic disease worse: WHO
- Stomach virus linked to chronic fatigue syndrome
- Managing Chronic Pain
- Medical marijuana user files human rights complaint over smoking laws
- Wickes Furniture files Chapter 11 bankruptcy
- Shaquille O'Neal files for divorce
- Google files patent for mobile commerce
- Craig files to withdraw guilty plea, blames news media
News Categories
745
522
479
347
1003
691
279
973
Top 10 News
- Texas Woman Claims to Have Found Mythical 'Chupacabra'
- Wireless technology hits security budgets
- Google Starts Hosting News on Website
- Study Focuses On Cancer Risk In Biologic Treatment For Rheumatoid Arthritis
- Google forced to push image in China
- Ho-hum, the guest's another candidate
- Microsoft purchase of RIM nice to consider, but unlikely
- Western School Board limits digital devices
- 'Spooky' science points to quantum internet
- Nuñez, gov. gamble on healthcare overhaul
Statistics
News:
News Categories:
News Read:
News Categories:
News Read:
5039
8
621
8
621